Frontiers in Neuroscience | Neuropharmacology

Review

Published on 26 May 2021

A2B Adenosine Receptors and Sphingosine 1-Phosphate Signaling Cross-Talk in Oligodendrogliogenesis

in Neuropharmacology

Elisabetta Coppi
Francesca Cencetti
Federica Cherchi
Martina Venturini
Chiara Donati
Paola Bruni
Felicita Pedata
Anna Maria Pugliese

Frontiers in Neuroscience

doi 10.3389/fnins.2021.677988

6,248 views
4 citations

Review

Published on 26 May 2021

Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?

in Neuropharmacology

Melinda Hersey
Amanda K. Bacon
Lydia G. Bailey
Mark A. Coggiano
Amy H. Newman
Lorenzo Leggio
Gianluigi Tanda

Frontiers in Neuroscience

doi 10.3389/fnins.2021.656475

13,310 views
21 citations

Review

Published on 25 May 2021

CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma

in Neuropharmacology

Luke Maggs
Giulia Cattaneo
Ali Emre Dal
Ali Sanjari Moghaddam
Soldano Ferrone

Frontiers in Neuroscience

doi 10.3389/fnins.2021.662064

52,303 views
139 citations

Review

Published on 17 May 2021

Methylene Blue Application to Lessen Pain: Its Analgesic Effect and Mechanism

in Neuropharmacology

Seung Won Lee
Hee Chul Han

Frontiers in Neuroscience

doi 10.3389/fnins.2021.663650

48,851 views
37 citations

Review

Published on 14 May 2021

Sleep and Memory Consolidation Dysfunction in Psychiatric Disorders: Evidence for the Involvement of Extracellular Matrix Molecules

in Neuropharmacology

Barbara Gisabella
Jobin Babu
Jake Valeri
Lindsay Rexrode
Harry Pantazopoulos

Frontiers in Neuroscience

doi 10.3389/fnins.2021.646678

8,677 views
13 citations

Review

Published on 13 May 2021

Astrocytes and Adenosine A2A Receptors: Active Players in Alzheimer’s Disease

in Neuropharmacology

Cátia R. Lopes
Rodrigo A. Cunha
Paula Agostinho

Frontiers in Neuroscience

doi 10.3389/fnins.2021.666710

10,656 views
41 citations

Original Research

Published on 06 May 2021

Tetramethylpyrazine Alleviates Behavioral and Psychological Symptoms of Dementia Through Facilitating Hippocampal Synaptic Plasticity in Rats With Chronic Cerebral Hypoperfusion

in Neuropharmacology

Zihu Tan
Jing Qiu
Yuting Zhang
Qiong Yang
Xixi Yin
Jia Li
Guangya Liu
Hengfei Li
Guang Yang

Frontiers in Neuroscience

doi 10.3389/fnins.2021.646537

7,087 views
10 citations

Review

Published on 05 May 2021

Neurochemistry of Visual Attention

in Neuropharmacology

Denise Elfriede Liesa Lockhofen
Christoph Mulert

Frontiers in Neuroscience

doi 10.3389/fnins.2021.643597

33,149 views
47 citations

Review

Published on 04 May 2021

Peripherally Acting Opioids in Orofacial Pain

in Neuropharmacology

Qing Liu
Hongwen He
Lijia Mai
Shengyan Yang
Wenguo Fan
Fang Huang

Frontiers in Neuroscience

doi 10.3389/fnins.2021.665445

5,272 views
10 citations

Original Research

Published on 30 Apr 2021

Chronic Ethanol Exposures Leads to a Negative Affective State in Female Rats That Is Accompanied by a Paradoxical Decrease in Ventral Hippocampus Excitability

in Neuropharmacology

Eva C. Bach
James W. Morgan
Sarah E. Ewin
Samuel H. Barth
Kimberly F. Raab-Graham
Jeffrey L. Weiner

Frontiers in Neuroscience

doi 10.3389/fnins.2021.669075

5,878 views
16 citations

Review

Published on 30 Apr 2021

Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?

in Neuropharmacology

Ezio Carboni
Anna R. Carta
Elena Carboni
Antonello Novelli

Frontiers in Neuroscience

doi 10.3389/fnins.2021.657714

36,800 views
23 citations

Original Research

Published on 28 Apr 2021

Valproic Acid Induces Autism-Like Synaptic and Behavioral Deficits by Disrupting Histone Acetylation of Prefrontal Cortex ALDH1A1 in Rats

in Neuropharmacology

Huan Liu
Mei Tan
Boli Cheng
Si Wang
Lu Xiao
Jiang Zhu
Qionghui Wu
Xi Lai
Qian Zhang
Jie Chen

Frontiers in Neuroscience

doi 10.3389/fnins.2021.641284

12,706 views
35 citations

Review

Published on 23 Apr 2021

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease

in Neuropharmacology

Angeles Vinuesa
Carlos Pomilio
Amal Gregosa
Melisa Bentivegna
Jessica Presa
Melina Bellotto
Flavia Saravia
Juan Beauquis

Frontiers in Neuroscience

doi 10.3389/fnins.2021.653651

15,701 views
83 citations

Original Research

Published on 20 Apr 2021

In silico Gene Set and Pathway Enrichment Analyses Highlight Involvement of Ion Transport in Cholinergic Pathways in Autism: Rationale for Nutritional Intervention

in Neuropharmacology

Audrey Olson
Fuquan Zhang
Hongbao Cao
Ancha Baranova
Margaret Slavin

Frontiers in Neuroscience

doi 10.3389/fnins.2021.648410

5,197 views
7 citations

Review

Published on 15 Apr 2021

Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities

in Neuropharmacology

Mark D. Namba
Jonna M. Leyrer-Jackson
Erin K. Nagy
M. Foster Olive
Janet L. Neisewander

Frontiers in Neuroscience

doi 10.3389/fnins.2021.650785

16,051 views
68 citations

Original Research

Published on 14 Apr 2021

Large-Volume Intrathecal Administrations: Impact on CSF Pressure and Safety Implications

in Neuropharmacology

Vasily Belov
Janine Appleton
Stepan Levin
Pilar Giffenig
Beata Durcanova
Mikhail Papisov

Frontiers in Neuroscience

doi 10.3389/fnins.2021.604197

15,366 views
36 citations

Review

Published on 12 Apr 2021

Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia

in Neuropharmacology

Qiongqiong Wu
Jing Huang
Renrong Wu

Frontiers in Neuroscience

doi 10.3389/fnins.2021.641047

12,180 views
22 citations

Original Research

Published on 09 Apr 2021

Reduced Expression of Hippocampal GluN2A-NMDAR Increases Seizure Susceptibility and Causes Deficits in Contextual Memory

in Neuropharmacology

Maria Florencia Acutain
Jordana Griebler Luft
Cecila Alejandra Vazquez
Bruno Popik
Magalí C. Cercato
Alberto Epstein
Anna Salvetti
Diana A. Jerusalinsky
Lucas de Oliveira Alvares
Maria Verónica Baez

Frontiers in Neuroscience

doi 10.3389/fnins.2021.644100

7,766 views
25 citations

Review

Published on 29 Mar 2021

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders

in Neuropharmacology

Yoo Jin Jung
David Tweedie
Michael T. Scerba
Dong Seok Kim
Maria Francesca Palmas
Augusta Pisanu
Anna R. Carta
Nigel H. Greig

Frontiers in Neuroscience

doi 10.3389/fnins.2021.656921

17,067 views
34 citations

Brief Research Report

Published on 24 Mar 2021

Effect of Ketamine on Human Neurochemistry in Posterior Cingulate Cortex: A Pilot Magnetic Resonance Spectroscopy Study at 3 Tesla

in Neuropharmacology

Petr Bednarik
Benjamin Spurny
Leo R. Silberbauer
Alena Svatkova
Patricia A. Handschuh
Birgit Reiter
Melisande E. Konadu
Thomas Stimpfl
Marie Spies
Wolfgang Bogner

Frontiers in Neuroscience

doi 10.3389/fnins.2021.609485

6,806 views
10 citations

Original Research

Published on 24 Mar 2021

PPAR γ Prevents Neuropathic Pain by Down-Regulating CX3CR1 and Attenuating M1 Activation of Microglia in the Spinal Cord of Rats Using a Sciatic Chronic Constriction Injury Model

in Neuropharmacology

Xilei Li
Qulian Guo
Zhi Ye
E. Wang
Wangyuan Zou
Zhihua Sun
Zhenghua He
Tao Zhong
Yingqi Weng
Yundan Pan

Frontiers in Neuroscience

doi 10.3389/fnins.2021.620525

8,212 views
27 citations

Review

Published on 23 Mar 2021

Drug Repurposing in the Treatment of Traumatic Brain Injury

in Neuropharmacology

Michael K. Ghiam
Shrey D. Patel
Alan Hoffer
Warren R. Selman
Barry J. Hoffer
Michael E. Hoffer

Frontiers in Neuroscience

doi 10.3389/fnins.2021.635483

17,003 views
31 citations

Original Research

Published on 23 Mar 2021

Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway

in Neuropharmacology

ZhengHu Xu
Dongfeng Yang
Xiaojing Huang
Huai Huang

Frontiers in Neuroscience

doi 10.3389/fnins.2021.631501

10,202 views
48 citations

Original Research

Published on 22 Mar 2021

Additive Effects of Environmental Enrichment and Ketamine on Neuropathic Pain Relief by Reducing Glutamatergic Activation in Spinal Cord Injury in Rats

in Neuropharmacology

W. L. Tai
L. Sun
H. Li
P. Gu
E. A. Joosten
C. W. Cheung

Frontiers in Neuroscience

doi 10.3389/fnins.2021.635187

5,310 views
18 citations

1,073 articles

articles

A2B Adenosine Receptors and Sphingosine 1-Phosphate Signaling Cross-Talk in Oligodendrogliogenesis

Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?

CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma

Methylene Blue Application to Lessen Pain: Its Analgesic Effect and Mechanism

Sleep and Memory Consolidation Dysfunction in Psychiatric Disorders: Evidence for the Involvement of Extracellular Matrix Molecules

Astrocytes and Adenosine A2A Receptors: Active Players in Alzheimer’s Disease

Tetramethylpyrazine Alleviates Behavioral and Psychological Symptoms of Dementia Through Facilitating Hippocampal Synaptic Plasticity in Rats With Chronic Cerebral Hypoperfusion

Neurochemistry of Visual Attention

Peripherally Acting Opioids in Orofacial Pain

Chronic Ethanol Exposures Leads to a Negative Affective State in Female Rats That Is Accompanied by a Paradoxical Decrease in Ventral Hippocampus Excitability

Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?

Valproic Acid Induces Autism-Like Synaptic and Behavioral Deficits by Disrupting Histone Acetylation of Prefrontal Cortex ALDH1A1 in Rats

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease

In silico Gene Set and Pathway Enrichment Analyses Highlight Involvement of Ion Transport in Cholinergic Pathways in Autism: Rationale for Nutritional Intervention

Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities

Large-Volume Intrathecal Administrations: Impact on CSF Pressure and Safety Implications

Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia

Reduced Expression of Hippocampal GluN2A-NMDAR Increases Seizure Susceptibility and Causes Deficits in Contextual Memory

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders

Effect of Ketamine on Human Neurochemistry in Posterior Cingulate Cortex: A Pilot Magnetic Resonance Spectroscopy Study at 3 Tesla

PPAR γ Prevents Neuropathic Pain by Down-Regulating CX3CR1 and Attenuating M1 Activation of Microglia in the Spinal Cord of Rats Using a Sciatic Chronic Constriction Injury Model

Drug Repurposing in the Treatment of Traumatic Brain Injury

Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway

Additive Effects of Environmental Enrichment and Ketamine on Neuropathic Pain Relief by Reducing Glutamatergic Activation in Spinal Cord Injury in Rats